Piotr Koslinski
Overview
Explore the profile of Piotr Koslinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koslinski P, Rzepinski L, Koba M, Maciejek Z, Kowalewski M, Daghir-Wojtkowiak E
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064122
: Multiple sclerosis (MS) and myasthenia gravis (MG) are autoimmune diseases that attack the central nervous system (CNS) and the neuromuscular junction, respectively. As the common pathogenesis of both diseases...
2.
Koslinski P, Pluskota R, Koba M, Siedlecki Z, Sniegocki M
Molecules
. 2023 Dec;
28(23).
PMID: 38067430
Brain tumors account for 1% of all cancers diagnosed de novo. Due to the specificity of the anatomical area in which they grow, they can cause significant neurological disorders and...
3.
Rzepinski L, Koslinski P, Kowalewski M, Koba M, Maciejek Z
Neurol Neurochir Pol
. 2023 Aug;
57(5):414-422.
PMID: 37526173
Aim Of The Study: Amino acid metabolism is crucial for regulating immune responses and can be monitored in blood serum samples. This study aimed to analyse serum amino acid profiles...
4.
Koslinski P, Rzepinski L, Daghir-Wojtkowiak E, Koba M, Maciejek Z
Amino Acids
. 2023 Jul;
55(9):1157-1172.
PMID: 37474707
Myasthenia gravis (MG) is an autoimmune disease characterized by weakness and rapid fatigue. Diagnostic methods used for myasthenia gravis are not conclusive and satisfactory, therefore it is necessary to develop...
5.
Rzepinski L, Koslinski P, Gackowski M, Koba M, Maciejek Z
J Clin Neurol
. 2022 Sep;
18(5):529-534.
PMID: 36062770
Background And Purpose: Aging in multiple sclerosis is associated with both disease- and age-dependent neurodegeneration. Serum metabolomic profiling of amino acids seems to be a promising method for searching for...
6.
Welz A, Koba M, Koslinski P, Siodmiak J
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407366
Recreational use of piperazine designer drugs is a serious threat to human health. These compounds act on the body in a similar fashion to illegal drugs. They induce psychostimulatory effects...
7.
Koslinski P, Rzepinski L, Koba M, Gackowski M, Maciejek Z
Folia Neuropathol
. 2022 Apr;
60(1):122-127.
PMID: 35359152
The search for new diagnostic and therapeutic approaches for myasthenia gravis (MG) is highly desirable. Therefore, the aim of the present study is to assess the profile of non-essential amino...
8.
Welz A, Koba M, Koslinski P, Siodmiak J
J Clin Med
. 2021 Dec;
10(24).
PMID: 34945109
Piperazine derivatives belong to the popular psychostimulating compounds from the group of designer drugs. They are an alternative to illegal drugs such as ecstasy and amphetamines. They are being searched...
9.
Pluskota R, Jaroch K, Koslinski P, Ziomkowska B, Lewinska A, Kruszewski S, et al.
Molecules
. 2021 Sep;
26(17).
PMID: 34500689
2-Arylidene-indan-1,3-done derivatives have very different properties, thanks to which they find various applications in science, medicine, and industry. Selected derivatives show antiviral, antibacterial, and anti-inflammatory activity. This paper presents a...
10.
Socha E, Koslinski P, Koba M, Madra-Gackowska K, Gackowski M, Kedziora-Kornatowska K, et al.
Amino Acids
. 2021 Jan;
53(1):97-109.
PMID: 33403465
Neurodegenerative disorders are one of the greatest global challenges for social and health care in the twenty-first century. Nowadays, determination of cerebrospinal fluid biomarkers for early diagnosis is served by...